John Mellors, Chair
University of Pittsburgh, USA
| Douglas Richman, Co-chair
VA San Diego Healthcare System and
University of California San Diego, USA |
Barry Bernstein
Abbott Laboratories
François Clavel
Inserm U552
Bonaventura Clotet
Fundacio IRSI Caixa
John Coffin
Tufts University
Abel De La Rosa
Pharmasset
Steven Deeks
University of California, San Francisco
James M. Goodrich
ViiV Healthcare
Matthias Götte
McGill University
Robert Grant
Gladstone/UCSF
Huldrych Günthard
University Hospital Zurich
David Hall
Boehringer Ingelheim Pharmaceuticals
George Hanna
Bristol-Myers Squibb
Richard Harrigan
BC Centre for Excellence in HIV/AIDS
Daria Hazuda
Merck Research Labs
Walid Heneine
Centers for Disease Control and Prevention
Rolf Kaiser
University of Cologne
Daniel Kuritzkes
Brigham and Women's Hospital
|
Susan Little
University of California, San Diego
Michael Miller
Gilead Sciences
Sarah Palmer
Swedish Institute for Infectious Disease Control, Karolinska Institutet, and Medivir
Jean-Michel Pawlotsky
Henri Mondor Hospital
Carlo-Federico Perno
University of Rome Tor Vergata, Italy
Christos Petropoulos
Monogram Biosciences
Gastón Picchio
Tibotec, Inc.
Deenan Pillay
University College London
Jonathan Schapiro
National Hemophilia Center - Israel
Celia Schiffer
University of Massachusetts Medical School
Raymond Schinazi
Emory University/VA Medical Center
Robert Shafer
Stanford University
David N. Stranding
Idenix Pharmaceuticals, Inc.
Lieven Stuyver
Tibotec-Virco
Mark Wainberg
McGill University AIDS Centre
Mike Westby
Pfizer Global R&D
|
